Practice parameter: Risk of driving and Alzheimer’s disease

To the Editor: We read with interest the recent practice parameter regarding risk of driving and AD by Dubinsky et al. that was based on a review of epidemiologic studies and driving performance studies assessing crash risk among drivers with AD.1 Two recommendations were made: 1) patients and their families should be told that patients with AD whose Clinical Dementia Rating (CDR) is 1 should not drive because of a substantially increased risk of crashing; and 2) patients and their families should be told that patients with possible AD and a CDR of 0.5 pose a significant traffic problem compared to other elder drivers. In this latter case, clinicians are advised to refer patients for an evaluation of driving performance by a qualified examiner and to assess dementia severity and appropriateness of continued driving every 6 months. With respect to who is at risk for application of the practice parameter, we studied the prevalence …

[1]  D. Foley,et al.  Driving Cessation in Older Men with Incident Dementia , 2000, Journal of the American Geriatrics Society.

[2]  E. C. Cerrelli,et al.  CRASH DATA AND RATES FOR AGE-SEX GROUPS OF DRIVERS, 1990 , 1992 .

[3]  S. Shefer,et al.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. , 1984, The New England journal of medicine.

[4]  J. Sparano,et al.  Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center. , 1999, Journal of acquired immune deficiency syndromes.

[5]  J R Shua-Haim,et al.  The “Co‐pilot” Driver Syndrome , 1996, Journal of the American Geriatrics Society.

[6]  G. Cable,et al.  Knowledge, Attitudes, and Practices of Geriatricians Regarding Patients with Dementia Who Are Potentially Dangerous Automobile Drivers: A National Survey , 2000, Journal of the American Geriatrics Society.

[7]  E. Masliah,et al.  Changes in pathological findings at autopsy in AIDS cases for the last 15 years , 2000, AIDS.

[8]  L. Larocca,et al.  AIDS-related focal brain lesions in the era of highly active antiretroviral therapy , 2000, Neurology.

[9]  K. Jellinger,et al.  Neuropathology and general autopsy findings in AIDS during the last 15 years , 2000, Acta Neuropathologica.

[10]  V. Beral,et al.  Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. , 2000, Journal of the National Cancer Institute.

[11]  A. C. Stein,et al.  Practice parameter: Risk of driving and Alzheimer’s disease (an evidence-based review) , 2000, Neurology.